Legend Biotech (LEGN) EBITDA Margin Growth (1y) (2020 - 2025)
Legend Biotech (LEGN) EBITDA Margin Growth (1y) (2020 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,609.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1,536.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -957.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,609.00 |
| Sep 30, 2025 | -2,469.00 |
| Jun 30, 2025 | -1,494.00 |
| Mar 31, 2025 | 9,407.00 |
| Dec 31, 2024 | -14,252.00 |
| Sep 30, 2024 | 12,546.00 |
| Jun 30, 2024 | 29,646.00 |
| Mar 31, 2024 | 15,666.00 |
| Dec 31, 2023 | -29,535.00 |
| Sep 30, 2023 | 23,993.00 |
| Jun 30, 2023 | 123,437.00 |
| Mar 31, 2023 | -19,385.00 |
| Dec 31, 2022 | 16,499.00 |
| Sep 30, 2022 | 40,022.00 |
| Jun 30, 2022 | -105,761.00 |
| Mar 31, 2022 | 48,200.00 |
| Dec 31, 2021 | 304.00 |
| Sep 30, 2021 | -15,455.00 |
| Jun 30, 2021 | -97,607.00 |
| Mar 31, 2021 | -104,827.00 |